GW
EVH icon

Glenn Welling’s Evolent Health EVH Stock Holding History

Glenn Welling’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.2M Hold
5,563,912
– – 9.22% 4
2026
Q1 		$12.7M Hold
5,563,912
– – 4.18% 7
2025
Q4 		$22.3M Sell
5,563,912
-100,000
-2% -$556K 5.68% 7
2025
Q3 		$47.9M Sell
5,663,912
-190,556
-3% -$1.85M 11.75% 4
2025
Q2 		$65.9M Buy
5,854,468
+675,000
+13% +$6.2M 18.43% 2
2025
Q1 		$49M Sell
5,179,468
-225,300
-4% -$2.28M 12.5% 5
2024
Q4 		$60.8M Buy
5,404,768
+1,415,300
+35% +$24.9M 12.5% 4
2024
Q3 		$113M Sell
3,989,468
-121,990
-3% -$3.14M 18.3% 1
2024
Q2 		$78.6M Buy
4,111,458
+850,000
+26% +$21.7M 13.46% 2
2024
Q1 		$107M Hold
3,261,458
– – 17.33% 1
2023
Q4 		$108M Buy
3,261,458
+428,648
+15% +$12.1M 15.78% 1
2023
Q3 		$77.1M Buy
2,832,810
+1,085,558
+62% +$30.2M 14.06% 5
2023
Q2 		$52.9M Sell
1,747,252
-466,202
-21% -$15.1M 7.66% 6
2023
Q1 		$71.8M Sell
2,213,454
-572,588
-21% -$18.1M 10.22% 5
2022
Q4 		$78.2M Buy
2,786,042
+544,050
+24% +$15.6M 13.23% 5
2022
Q3 		$80.6M Sell
2,241,992
-3,912,829
-64% -$138M 15.93% 4
2022
Q2 		$189M Sell
6,154,821
-991,574
-14% -$28.9M 29.02% 1
2022
Q1 		$231M Sell
7,146,395
-683,297
-9% -$17.9M 22.46% 2
2021
Q4 		$217M Sell
7,829,692
-63,502
-0.8% -$1.82M 26.68% 1
2021
Q3 		$245M Sell
7,893,194
-659,961
-8% -$15.8M 17.58% 2
2021
Q2 		$181M Hold
8,553,155
– – 13.99% 2
2021
Q1 		$173M Hold
8,553,155
– – 12.48% 2
2020
Q4 		$137M Hold
8,553,155
– – 11.31% 2
2020
Q3 		$106M Buy
+8,553,155
New +$101M 10.98% 2

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenn Welling's EVH Position: Q2 2026 in Review

Glenn Welling held its Evolent Health (EVH) position steady in Q2 2026 at 5,563,912 shares worth $30.2M. The position accounts for 9.22% of the portfolio, ranked #4.

Glenn Welling first reported a position in EVH in Q3 2020 and has held it in 24 quarters since. The position peaked at $245M in Q3 2021. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Glenn Welling held 5,563,912 shares of Evolent Health worth $30.2M as of Q2 2026.
  • Glenn Welling left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up 9.22% of Glenn Welling's portfolio in Q2 2026, its #4 holding.
  • Glenn Welling first reported a position in Evolent Health in Q3 2020 and has held it in 24 quarters since.
  • Glenn Welling's Evolent Health position peaked at $245M in Q3 2021.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Engaged Capital's 13F filing for Q2 2026, filed 14 Aug 2026.